Good afternoon, everyone, and welcome to the Maravai LifeSciences Q1 2025 Results Earnings Call. [Operator Instructions] Also, today's call is being recorded. [Operator Instructions] At this time, ...

For more information about these risks and uncertainties, please refer to the Risk Factors section of AST SpaceMobile's Annual Report on Form 10-K for the year that ended, December 31, 2024, with the ...

After treatment with CAR-T cells—immune cells engineered to attack cancer—patients sometimes tell their doctors they feel ...

Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in ...

A rapidly developed, dual-target chimeric antigen receptor T-cell therapy produced a 100% overall response rate in patients ...

Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for neurodegenerative conditions like Parkinson's and Alzheimer's. The team has identified a small ...

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...